BFC Planning’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.14K Hold
25
– – ﹤0.01% 2988
2026
Q2
$2.93K Sell
25
-16
-39% -$1.61K ﹤0.01% 2884
2026
Q1
$3.79K Hold
41
– – ﹤0.01% 2411
2025
Q4
$3.24K Buy
+41
New +$2.94K ﹤0.01% 2489

Other funds holding MIRM

BFC Planning's MIRM Position: Q3 2026 in Review

BFC Planning held its Mirum Pharmaceuticals (MIRM) position steady in Q3 2026 at 25 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

BFC Planning first reported a position in MIRM in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.79K in Q1 2026. 231 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • BFC Planning held 25 shares of Mirum Pharmaceuticals worth $2.14K as of Q3 2026.
  • BFC Planning left its Mirum Pharmaceuticals share count unchanged in Q3 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2988 holding.
  • BFC Planning first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • BFC Planning's Mirum Pharmaceuticals position peaked at $3.79K in Q1 2026.
  • 231 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.